Free Trial
NASDAQ:FRTX

Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis

Fresh Tracks Therapeutics logo
$0.94 -0.01 (-0.53%)
As of 02/28/2025

About Fresh Tracks Therapeutics Stock (NASDAQ:FRTX)

Key Stats

Today's Range
$0.94
$0.94
50-Day Range
$0.69
$0.94
52-Week Range
$0.03
$1.03
Volume
2,402 shs
Average Volume
2,709 shs
Market Capitalization
$5.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Remove Ads
Receive FRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresh Tracks Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FRTX Stock News Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
Fresh Tracks Therapeutics Inc (FRTX)
See More Headlines

FRTX Stock Analysis - Frequently Asked Questions

Fresh Tracks Therapeutics' stock was trading at $0.74 at the start of the year. Since then, FRTX shares have increased by 26.4% and is now trading at $0.9350.
View the best growth stocks for 2025 here
.

Shares of FRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresh Tracks Therapeutics investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Today
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:FRTX
Web
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.06 million
Price / Cash Flow
N/A
Book Value
$1.66 per share
Price / Book
0.56

Miscellaneous

Free Float
5,959,000
Market Cap
$5.58 million
Optionable
Not Optionable
Beta
0.54
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:FRTX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners